Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors

Overview of attention for article published in American Journal of Clinical Oncology: Cancer Clinical Trials, July 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 4 X posts from 1 X users, with an upper bound of 906 followers.

New article: Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors https://t.co/UHR0Mwwtdb #gastriccancer #oncology https://t.co/2tbujZHcNq

New article: Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors https://t.co/WDCZKnpR76 #breastcancer #oncology https://t.co/aASfO9qE25

New article: Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors https://t.co/S2ItAZXxmy #prostatecancer #oncology https://t.co/1PmFLgXoiZ

New article: Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors https://t.co/lOEXJLZNwU #lungcancer #oncology https://t.co/pThXM8l0Os

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.